Without IRT Integration
Meliovit’s capability to operate independently of IRT systems provides a flexible solution for trials that require or prefer manual management.
Our platform is committed to providing tailored solutions that meet the unique needs of each study, ensuring the success and integrity of clinical trials worldwide.
Learn moreMeliovit offers a versatile platform for managing clinical trials, designed to function seamlessly both with and without IRT (Interactive Response Technology) integration.
Our flexibility allows for tailored approaches to participant registration and medicinal product dispatching, ensuring the system aligns perfectly with the specific operational needs of each trial.
When integrated with IRT systems, Meliovit streamlines the trial management process, enhancing efficiency and reducing manual workload.
Subject IDs created in the IRT software are automatically transferred to Meliovit, along with their assigned site. Investigators are notified and can promptly proceed to input participant contact details.
IRT software automatically raises the shipment order and sends the IMP box number and Subject ID match to Meliovit. Meliovit, based on the predefined study setup, determines the required delivery route (e.g., from Central Depot (Hub A) to Site Pharmacy (Hub B) to the participant) and forwards the necessary details to the various Shipments Hub users for processing.
Reduces the possibility of manual errors and speeds up the process of shipping and participant management.
Meliovit’s capability to operate independently of IRT systems provides a flexible solution for trials that require or prefer manual management.
Investigators manually register Subject IDs and enter participant contact details directly into Meliovit.
Investigators manually select participants for shipment and enter the specific IMP box number and other items to be delivered. The system then automatically determines the required delivery route based on the study’s setup in Meliovit.
Once a shipment is raised, it is automatically directed to the appropriate hub (e.g., the first hub in the sequence) for processing.
Without the need for integration with other software systems, the non-IRT approach allows for a faster implementation, enabling clinical trials to commence with minimal delay and reduced complexity in the initial setup phase.
Both integration modes provide robust support for clinical trials, with IRT integration offering a more automated, streamlined process, and the non-IRT setup providing a more straightforward implementation. This dual capability ensures that Meliovit can adapt to various trial designs and requirements, maintaining its commitment to efficient and accurate logistics management in any setup.
Meliovit leads in customizable trial management, catering to diverse distribution models. Our system adapts to Site-to-Patient, Site Pharmacy-to-Patient, Delegated Pharmacy-to-Patient, Manufacturer-to-Patient, Depot-to-Patient, or hybrid setups, integrating seamlessly with trial logistics.
In Meliovit, any location involved in the processing and dispatching of Investigational Medicinal Products (IMPs) to participants is designated as a “Hub”. This could be a Site Pharmacy, Delegated Pharmacy, Manufacturer, Local Depot, Central Depot, or even a Site.
Depending on the trial’s needs, multiple hubs like the Central Depot and Site can be set up and configured in Meliovit. For example, in a Site-to-Patient model, IMPs can be dispatched from the Site Hub directly to participants. In scenarios where ancillary items or insulated shipping systems (ISS) are required, these can be first sent from the Central Depot (Hub A) to the Site (Hub B), and then packaged together with the IMP for final delivery to the participant.
Meliovit’s adaptability extends to catering to different requirements based on geographic locations. In one country, a trial might utilize a Site-to-Patient model, while another might require a Site Pharmacy-to-Patient approach. Meliovit can seamlessly adjust to these varying requirements, adding and defining hubs as necessary for each country within the same study.
For each trial setup, the process flow can be meticulously adjusted in Meliovit. In the case of a Site-to-Patient model, the Site can be added as a Hub, with the system accommodating the direct dispatch of trial materials from the Site to the participant. Relationships between different hubs and participant endpoints are customizable to ensure efficient and accurate delivery paths.
Meliovit recognizes the importance of Nursing Assistance in clinical trials, especially for receipt, administration, or return of shipments. The system can integrate these requirements into the delivery process, ensuring that nursing staff is adequately informed and prepared to assist participants as needed.
Regardless of the complexity or diversity of the trial design, Meliovit provides a coherent and streamlined management solution. Our system’s flexibility in hub configuration and distribution models, coupled with the capability to incorporate nursing assistance, makes it an ideal choice for modern, diverse, and complex clinical trials.
